Loading organizations...

Medmo is a technology company.
Medmo provides a digital healthcare platform designed to streamline the process of ordering, scheduling, and tracking medical imaging appointments. The company's technology solution connects referring providers and their patients with local medical centers, facilitating access to a variety of diagnostic scanning services. This orchestration aims to simplify what can often be a complex and fragmented patient journey for essential medical tests.
The company was founded in 2017 by Shaun Elliot Tobias and Christopher Kelly. Their insight stemmed from recognizing the inefficiencies and challenges inherent in the traditional medical imaging referral and scheduling landscape. They aimed to develop a centralized system that could improve accessibility and coordination for all parties involved in the diagnostic imaging workflow.
Medmo primarily serves healthcare providers, including physicians, and their patients who require medical imaging services, as well as the imaging centers that perform these diagnostics. The company's vision centers on optimizing the entire medical imaging ecosystem, ensuring that patients receive timely and appropriate care while offering providers a more efficient way to manage referrals and follow-ups.
Medmo has raised $29.0M across 3 funding rounds.
Medmo has raised $29.0M in total across 3 funding rounds.
Medmo has raised $29.0M in total across 3 funding rounds.
Medmo's investors include Ron Vianu, Gradient Ventures, Gadi Porat, Lerer Hippeau, Elliott Cohen, Digital Health Venture Partners, Origin Ventures, TGVP, Isabelle Phelps, Elliot Cohen, Simon Bolz, Simon Lorenz.
Medmo is a healthcare technology startup that provides an AI-powered platform for providers to order, schedule, and track medical imaging appointments like MRIs, CT scans, and PET scans.[2][4] It serves ordering providers across specialties, including orthopedics, in all 50 states, solving inefficiencies in imaging referrals such as delayed appointments, low adherence rates, high administrative costs, and exams in expensive settings by guiding patients to high-value in-network centers, boosting completion rates, and closing the care loop with real-time updates.[2][4] Medmo has raised $15 million in a Series A round and previously $9 million in funding, demonstrating strong growth momentum with partnerships like Sorin Medical and claims of 30% higher patient adherence and 95% reduced staff time on referrals for clients.[1][4][5]
Medmo was founded in 2017 and incorporated on October 27, 2017, in New York City, with Dr. Christopher Kelly MD as CEO and Lucas Takahashi as co-founder.[3] Operating from 122 Grand Street in Chinatown, NY, the company emerged to address patient pain points in medical imaging—long waits, unnecessary travel, and high costs—while easing administrative burdens for providers and optimizing capacity for imaging centers.[3][5] Early traction included BBB accreditation in 2019 and funding rounds, with a $9 million raise led by Lerer Hippeau alongside Jerusalem Venture Partners (JVP), C2 Ventures, Stone IsraVentures, and angels, followed by a $15 million Series A to fuel expansion.[1][5]
Medmo rides the value-based care trend in healthcare, where reducing costs and improving outcomes amid rising imaging expenses aligns with payer pressures and regulations like HEDIS/Star ratings.[2][4] Its timing capitalizes on post-pandemic diagnostic backlogs, AI-driven coordination needs, and a fragmented $100+ billion U.S. imaging market strained by administrative inefficiencies.[4][5] Market forces favoring Medmo include health system consolidation, insurer demands for in-network utilization, and tech adoption by 60%+ of U.S. systems via platforms like Elion, positioning it to influence ecosystems by streamlining referrals and boosting adherence across providers.[2]
Medmo's platform positions it for scaled adoption as AI care coordination matures, with next steps likely expanding enterprise partnerships, enhancing AI for predictive scheduling, and entering adjacent diagnostics amid value-based shifts.[4][5] Trends like telehealth integration and payer-provider alignments will amplify its efficiencies, potentially evolving its influence from niche imaging optimizer to broader diagnostic orchestrator, tying back to its core mission of making high-quality care accessible and seamless for patients and providers.[2][4]
Medmo has raised $29.0M across 3 funding rounds. Most recently, it raised $15.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $15.0M Series A | Ron Vianu | Gradient Ventures, Gadi Porat, Lerer Hippeau, Elliott Cohen, Digital Health Venture Partners, Origin Ventures, TGVP |
| Nov 20, 2023 | $9.0M Other Equity | Isabelle Phelps | Elliot Cohen, Simon Bolz, Simon Lorenz, C2 Ventures, Gadi Porat, Stone IsraVentures |
| Nov 1, 2023 | $5.0M Seed | D.F.A. Capital, FirstHand Alliance, Gradient Ventures, Gadi Porat, Jerusalem Venture Partners (JVP), Lerer Hippeau, MizMaa Ventures, Pantera Capital, Tucker Seed Fund LLC, Vast Ventures, Elliott Cohen |